Lite Strategy, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lite Strategy, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $65.30M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | $48.82M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $40.70M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $34.80M | Sep 8, 2022 |
| FY2020 | Jun 30, 2020 | $25.50M | Sep 9, 2020 |
| FY2020 | Mar 31, 2020 | $1.24M | Sep 9, 2020 |
| FY2020 | Dec 31, 2019 | $1.01M | Sep 9, 2020 |
| FY2020 | Sep 30, 2019 | $1.16M | Sep 9, 2020 |
| FY2020 | Jun 30, 2019 | $1.13M | Sep 9, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($15.95M) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $17.78M | Sep 26, 2025 |
| FY2025 | Jun 30, 2023 | ($32.00M) | Sep 26, 2025 |
| FY2023 | Jun 30, 2022 | ($54.00M) | Oct 27, 2023 |
| FY2023 | Jun 30, 2021 | ($41.00M) | Oct 27, 2023 |
| FY2020 | Jun 30, 2020 | ($18.48M) | Sep 9, 2020 |
| FY2020 | Mar 31, 2020 | ($4.33M) | Sep 9, 2020 |
| FY2020 | Dec 31, 2019 | ($20.22M) | Sep 9, 2020 |
| FY2020 | Sep 30, 2019 | ($2.99M) | Sep 9, 2020 |
| FY2020 | Jun 30, 2019 | $3.05M | Sep 9, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($17.46M) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $14.54M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | ($36.76M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($75.48M) | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | ($60.42M) | Sep 8, 2022 |
| FY2022 | Jun 30, 2020 | ($25.70M) | Sep 8, 2022 |
| FY2021 | Jun 30, 2019 | ($46.25M) | May 23, 2022 |
| FY2020 | Jun 30, 2018 | ($28.59M) | Sep 9, 2020 |
| FY2019 | Jun 30, 2017 | $2.38M | Aug 28, 2019 |
| FY2018 | Jun 30, 2016 | ($21.00M) | Aug 30, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.92M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $16.56M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | $52.45M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $85.64M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $69.40M | Sep 8, 2022 |
| FY2022 | Jun 30, 2020 | $34.07M | Sep 8, 2022 |
| FY2021 | Jun 30, 2019 | $32.30M | May 23, 2022 |
| FY2020 | Jun 30, 2018 | $17.04M | Sep 9, 2020 |
| FY2019 | Jun 30, 2017 | $7.24M | Aug 28, 2019 |
| FY2018 | Jun 30, 2016 | $13.40M | Aug 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($20.84M) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | ($50.47M) | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | ($52.48M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($48.75M) | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | ($31.96M) | Sep 8, 2022 |
| FY2022 | Jun 30, 2020 | $34.26M | Sep 8, 2022 |
| FY2021 | Jun 30, 2019 | ($29.42M) | May 23, 2022 |
| FY2020 | Jun 30, 2018 | ($21.04M) | Sep 9, 2020 |
| FY2019 | Jun 30, 2017 | $3.49M | Aug 28, 2019 |
| FY2018 | Jun 30, 2016 | ($17.86M) | Aug 30, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $7.0K | Sep 26, 2025 |
| FY2023 | Jun 30, 2023 | $35.0K | Sep 26, 2023 |
| FY2023 | Jun 30, 2022 | $479.0K | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $708.0K | Sep 8, 2022 |
| FY2022 | Jun 30, 2020 | $894.0K | Sep 8, 2022 |
| FY2021 | Jun 30, 2019 | $217.0K | May 23, 2022 |
| FY2019 | Jun 30, 2017 | $51.0K | Aug 28, 2019 |
| FY2018 | Jun 30, 2016 | $4.0K | Aug 30, 2018 |
| FY2017 | Jun 30, 2015 | $15.0K | Sep 5, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $18.29M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $41.38M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | $120.81M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $177.84M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $174.10M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $209.73M | May 23, 2022 |
| FY2020 | Jun 30, 2019 | $82.66M | Sep 9, 2020 |
| FY2019 | Jun 30, 2018 | $104.66M | Aug 28, 2019 |
| FY2018 | Jun 30, 2017 | $55.70M | Aug 30, 2018 |
| FY2017 | Jun 30, 2016 | $47.16M | Sep 5, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.35M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $8.36M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | $96.19M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $125.43M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $124.63M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $132.67M | May 23, 2022 |
| FY2020 | Jun 30, 2019 | $34.73M | Sep 9, 2020 |
| FY2019 | Jun 30, 2018 | $54.20M | Aug 28, 2019 |
| FY2018 | Jun 30, 2017 | $4.87M | Aug 30, 2018 |
| FY2012 | Jun 30, 2012 | $1.77M | Sep 18, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $16.93M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $33.02M | Sep 26, 2025 |
| FY2025 | Jun 30, 2023 | $24.62M | Sep 26, 2025 |
| FY2024 | Jun 30, 2022 | $52.41M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $49.47M | Sep 26, 2023 |
| FY2022 | Jun 30, 2020 | $77.06M | Sep 8, 2022 |
| FY2022 | Jun 30, 2019 | $47.93M | Sep 8, 2022 |
| FY2021 | Jun 30, 2018 | $50.46M | May 23, 2022 |
| FY2020 | Jun 30, 2017 | $50.84M | Sep 9, 2020 |
| FY2019 | Jun 30, 2016 | $41.65M | Aug 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($404.16M) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | ($388.22M) | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | ($406.00M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($374.16M) | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | ($319.71M) | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | ($278.39M) | May 23, 2022 |
| FY2020 | Jun 30, 2019 | ($231.22M) | Sep 9, 2020 |
| FY2019 | Jun 30, 2018 | ($214.40M) | Aug 28, 2019 |
| FY2018 | Jun 30, 2017 | ($174.33M) | Aug 30, 2018 |
| FY2017 | Jun 30, 2016 | ($177.00M) | Sep 5, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $18.01M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | $3.71M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | $16.91M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $15.74M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | $8.54M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $12.33M | May 23, 2022 |
| FY2021 | Jun 30, 2019 | $9.59M | Sep 2, 2021 |
| FY2021 | Jun 30, 2018 | $13.31M | Sep 2, 2021 |
| FY2020 | Jun 30, 2017 | $8.46M | Sep 9, 2020 |
| FY2019 | Jun 30, 2016 | $10.84M | Aug 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (2) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | 2 | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | (4) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | (8) | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 8, 2022 |
| FY2020 | Jun 30, 2020 | 0 | Sep 9, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 9, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 9, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 9, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Sep 9, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (2) | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | 2 | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | (4) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | (9) | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 8, 2022 |
| FY2020 | Jun 30, 2020 | 0 | Sep 9, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 9, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 9, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 9, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Sep 9, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6.66M | Sep 26, 2025 |
| FY2025 | Jun 30, 2024 | 6.66M | Sep 26, 2025 |
| FY2024 | Jun 30, 2023 | 6.66M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | 6.66M | Sep 26, 2023 |
| FY2022 | Jun 30, 2021 | 112.62M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | 111.51M | May 23, 2022 |
| FY2020 | Jun 30, 2019 | 73.55M | Sep 9, 2020 |
| FY2019 | Jun 30, 2018 | 70.41M | Aug 28, 2019 |
| FY2018 | Jun 30, 2017 | 36.77M | Aug 30, 2018 |
| FY2017 | Jun 30, 2016 | 34.16M | Sep 5, 2017 |